Showing results (301-310 of 322) with videos related to
Sort By:
Pageof 33
Kidney International|June 15, 2012
NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney diseaseThomas L Nickolas, Catherine S Forster, Meghan E Sise, et al.Science Translational Medicine|May 31, 2013
Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicityVishnu Chintalgattu, Meredith L Rees, James C Culver, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2019
Prevalence and Risk Factors for CKD Among Brickmaking Workers in La Paz Centro, NicaraguaLyanne Gallo-Ruiz, Caryn M Sennett, Mauricio Sánchez-Delgado, et al.Oncogene|January 29, 2008
Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavityG Zhou, T-X Xie, M Zhao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2023
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic CarcinomaRenata Ferrarotto, Luana G Sousa, Lei Feng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2020
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic TargetsRenata Ferrarotto, Yoshitsugu Mitani, Daniel J McGrail, et al.Nature Medicine|August 13, 2021
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.Annals of Surgical Oncology|February 11, 2018
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or ParagangliomaMinerva A Romero Arenas, Thereasa A Rich, Samuel M Hyde, et al.Cancer Research Communications|August 5, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology TrialsEsther J Beck, Alexander D Sherry, Marcus A Florez, et al.JAMA Otolaryngology-- Head & Neck Surgery|September 25, 2015
Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional StudyJohn R de Almeida, Ryan Li, J Scott Magnuson, et al.Pageof 33